Characterization of novel dual A2A/A2B adenosine receptor antagonists for cancer immunotherapy

被引：4

作者：

Galezowski, Michal ^{[1
]}

Wegrzyn, Paulina ^{[1
]}

Bobowska, Aneta ^{[1
]}

Commandeur, Claude ^{[1
]}

Dziedzic, Katarzyna ^{[1
]}

Nowogrodzki, Marcin ^{[1
]}

Obara, Alicja ^{[1
]}

Szeremeta-Spisak, Joanna ^{[1
]}

Dzielak, Anna ^{[1
]}

Lozinska, Iwona ^{[1
]}

Dudek, Marcelina ^{[1
]}

Janiga, Anita ^{[1
]}

Reus, Jacek ^{[1
]}

Wronowski, Marek ^{[1
]}

Swirski, Mateusz ^{[1
]}

Radzimierski, Adam ^{[1
]}

Ziembik, Magdalena ^{[1
]}

Mierzwicka, Joanna ^{[1
]}

Wojcik-Jaszczynska, Katarzyna ^{[1
]}

Gocek, Elzbieta ^{[1
]}

Grycuk, Karolina ^{[1
]}

Golas, Aniela ^{[1
]}

Pierzchala, Olga ^{[1
]}

Zachmann, Julian ^{[1
]}

Nowak, Mateusz ^{[1
]}

机构：

[1] Selvita SA, Krakow, Poland

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-3770

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3770

引用

页数：2

共 50 条

[1] Novel dual A2A A2B adenosine receptor antagonists for cancer immunotherapy: in vitro and in vivo characterization
Galezowski, Michal
Wegrzyn, Paulina
Bobowska, Aneta
Dziedzic, Katarzyna
Szeremeta-Spisak, Joanna
Nowogrodzki, Marcin
Satala, Grzegorz
Obara, Alicja
Lozinska-Raj, Iwona
Dudek, Marcelina
Janiga, Anita
Reus, Jacek
Wronowski, Marek
Zastawna, Magdalena
Statkiewicz, Grzegorz
Rogacki, Maciej
Ziembik, Magdalena
Grycuk, Karolina
Soukou, Foteini
Michalik, Kinga
Adamus, Agnieszka
Wiatrowska, Karolina
Lewandowska, Natalia
Golas, Aniela
Haberkiewicz, Olga
Porter, Rod
Brzozka, Krzysztof
Nowak, Mateusz
CANCER RESEARCH, 2019, 79 (13)
[2] Adenosine A2A Receptor Antagonists for Cancer Immunotherapy
Yu, Fazhi
Zhu, Chenyu
Xie, Qiong
Wang, Yonghui
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (21) : 12196 - 12212
[3] Discovery and characterization of INCB106385: a novel A2A/A2B adenosine receptor antagonist, as a cancer immunotherapy.
Wang, Hui
Alexandra, Alexandra
Hansbury, Michael
Mason, Jennifer
Harris, Jennifer
Stevens, Christina
Maddage, Christopher
Ren, Xiaodi
Gao, Mingming
Kurzeja-Lipinski, Kerri
Yang, Gengjie
Conlen, Patricia
Stump, Kristine
Feldman, Patricia
Thekkat, Pramod
Lin, Luping
Covington, Maryanne
Yeleswaram, Swamy
Qi, Chao
Wang, Xiaozhao
Yao, Wenqing
Kim, Sunkyu
Wee, Susan
Chen, Yingnan
Koblish, Holly
CANCER RESEARCH, 2021, 81 (13)
[4] Discovery and characterization of a novel triple A1/A2a/A2b adenosine receptor antagonist for cancer immunotherapy.
Jang, Sunyoung
Jun, Seunah
Lee, Hosun
Lee, Yongtaek
Byun, Joo-Yun
Park, Junghwa
Kim, Yu-Yon
Ahn, Young Gil
Suh, Kwee Hyun
CANCER RESEARCH, 2021, 81 (13)
[5] Discovery of Etrumadenant, a first-in-class dual A2a and A2b adenosine receptor antagonist for cancer immunotherapy
Sharif, Ehesan U.
Miles, Dillon H.
Rosen, Brandon R.
Beatty, Joel
Jeffrey, Jenna L.
Debien, Laurent P. P.
Thomas-Tran, Rhiannon
Mandal, Debashis
Direnzo, Dan
Marubayashi, Sachie
Zhang, Kristen
Soriano, Ferdie
Ginn, Elaine
Soni, Divyank
Chen, Pei-Yu
Jin, Lixia
Young, Steve W.
Walters, Matt J.
Leleti, Manmohan R.
Powers, Jay P.
MOLECULAR CANCER THERAPEUTICS, 2024, 23 (12)
[6] Antinociceptive effects of novel A2B adenosine receptor antagonists
Abo-Salem, OM
Hayallah, AM
Bilkei-Gorzo, A
Filipek, B
Zimmer, A
Müller, CE
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (01): : 358 - 366
[7] Release of adenosine-induced immunosuppression: Comprehensive characterization of dual A2A/A2B receptor antagonist
Dziedzic, Katarzyna
Wegrzyn, Paulina
Galezowski, Michal
Bonkowska, Magdalena
Grycuk, Karolina
Satala, Grzegorz
Wiatrowska, Karolina
Wiklik, Katarzyna
Brzozka, Krzysztof
Nowak, Mateusz
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
[8] Novel dual A2A/A2B receptor antagonist reverses adenosine-mediated immune suppression - in vitro and in vivo characterization
Galezowski, Michal
Wegrzyn, Paulina
Bobowska, Aneta
Dziedzic, Katarzyna
Bonkowska, Magdalena
Grycuk, Karolina
Szeremeta-Spisak, Joanna
Nowogrodzki, Marcin
Satala, Grzegorz
Obara, Alicja
Lozinska-Raj, Iwona
Wyrebek, Przemyslaw
Dudek, Marcelina
Janiga, Anita
Reus, Jacek
Wronowski, Marek
Zastawna, Magdalena
Statkiewicz, Grzegorz
Rogacki, Maciej
Swirski, Mateusz
Woyciechowski, Jakub
Michalik, Kinga
Adamus, Agnieszka
Wiatrowska, Karolina
Literska, Natalia
Golas, Aniela
Haberkiewicz, Olga
Stasi, Luigi
Littlewood, Peter
Brzozka, Krzysztof
Nowak, Mateusz
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[9] Prodrugs of A2B adenosine receptor antagonists
Kalla, Rao
Elzein, Elfatih
Koltun, Dmitry
Li, Xiaofen
Perry, Thao
Parkhill, Eric
Zeng, Dewan
Fong, Irving
Leung, Kwan
Zablocki, Jeff
PURINERGIC SIGNALLING, 2008, 4 : S21 - S22
[10] Irreversible Antagonists for the Adenosine A2B Receptor
Temirak, Ahmed
Schlegel, Jonathan G.
Voss, Jan H.
Vaassen, Victoria J.
Vielmuth, Christin
Claff, Tobias
Mueller, Christa E.
MOLECULES, 2022, 27 (12):

← 1 2 3 4 5 →